WELL News Shareholder Update Regarding Capsalus
Post# of 145170
WELL News Shareholder Update Regarding Capsalus Revenue Reporting Delay on Fiscal 2011 10-K Annual Report
2012-04-23 10:00 ET - News Release
Company Website: http://www.capsalus.com
ATLANTA -- (Business Wire)
Capsalus Corp. (OTCBB: WELL and, temporarily, OTCBB: WELLE), today announced that the necessary revenue numbers for its fourth quarter are not yet available to include in its Fiscal 2011 10-K annual report for the fiscal year ending Dec. 31, 2011 due to a required change in GeneLink Biosciences, Inc. (OTCBB: GNLK) auditors.
On Feb. 16, Capsalus had announced the completed acquisition of the stock of GeneWize Life Sciences, Inc., the wholly-owned direct-selling subsidiary of GeneLink Biosciences, a leader in consumer genomics. The deal provided immediate revenues.
Due to the unavailability of the fourth quarter audited financials, an "E" symbol was placed on Capsalus’ ticker symbol by the OTC Bulletin Board, informing the company that it had 30 days to file the annual report. Capsalus is actively working with the new auditors at GeneLink to have the "E" symbol removed as quickly as possible.
For more information about Capsalus, visit www.capsalus.com or call 888-400-7179.
(0)
(0)